Anne Wojcicki has a new offer to take 23andMe private, this time for $74.7 million 23andMe CEO Anne Wojcicki and New Mountain Capital have submitted a proposal to take the company private.

23andMe is exploring strategic alternatives, looking to raise capital 23andMe said it’s started exploring strategic alternatives, including a possible sale.

23andMe reports sales decline a day after announcing plans to cut 40% of workforce Embattled genetic testing provider 23andMe said Tuesday that revenue declined from a year earlier, a day after the company announced a cost-cutting plan.

23andMe is ending its cancer research program and slashing over 200 jobs Photo by Justin Sullivan/Getty Images23andMe is laying off 40 percent of its employees, or over 200 workers, as the company attempts to recover from last year’s massive data breach and reverse its plummeting stock price. The genetic testing company also announced that it will shut down its therapeutics business. Though 23andMe says the restructu…

Inside the fall of 23andMe Once worth $6 billion, 23andMe has lost 98% of its value and is on the verge of being delisted from the Nasdaq. So what happened?